B
한국비티비
219750KOSDAQ의료용 기기 제조업55.3 / 100
Reference Date: 2026-07-24
Financial Score11.0 / 40
News Sentiment21.3 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Surged 242.4% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Hanbitbi, established in 1999, is a medical device and biotechnology company that merged with Dongin Biotech in 2024, rebranding as Hanbitbi. Its Medical Device Division produces and sells anti-aging and beauty devices, including home beauty equipment, while the Bio Business Division supplies research reagents and equipment to biotech industries.
Number of Employees
100people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 20.044.0Point
PBR
1.05Industry Average 1.144.0Point
In line with industry avg
ROE
-14.97Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
54.19Industry Average 11.650.0Point
4.7x industry avg (risky)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲511.6% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼137.6% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -177.3% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85
- Positive코스닥시장본부, 25일 한국비티비 주권매매거래정지 해제
한국비티비의 주권매매거래 재개로 투자자들의 활동 재개 기대감 증가.
Detailed Momentum
52-week position6.0Point
52w upper range (75%)
Current 1,955Won52-week high 2,39552-week low 571
1-month return6.0Point
1m +242.38% (strong rise)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral주식등의대량보유상황보고서(일반)2026-07-06
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-06
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-06